Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy

Gastroenterology. 2024 Jun;166(6):1193. doi: 10.1053/j.gastro.2023.10.018. Epub 2023 Oct 20.

Author

Affiliation

¹ College of Medicine, Chang Gung University, Liver Research Unit, Chang Gung Memorial Hospital, Taipei, Taiwan.

PMID: 37866763
DOI: 10.1053/j.gastro.2023.10.018

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents* / adverse effects
Antiviral Agents* / therapeutic use
DNA, Viral / analysis
DNA, Viral / blood
Female
Hepatitis B / diagnosis
Hepatitis B / drug therapy
Hepatitis B Surface Antigens* / blood
Hepatitis B virus* / drug effects
Hepatitis B virus* / immunology
Hepatitis B virus* / isolation & purification
Hepatitis B, Chronic* / diagnosis
Hepatitis B, Chronic* / drug therapy
Hepatitis B, Chronic* / virology
Humans
Male
Middle Aged
Predictive Value of Tests
Recurrence*
Treatment Outcome